combretastatin A4 (Henry Ford Health System)

N/A

Report date: 2025/01/26 16:41:58
NME

Base Information

Drug Namecombretastatin A4 (Henry Ford Health System)
Drug Alias Namewater insoluble combretastatin conjugated to water soluble G3-succinamic acid PAMAM dendrimer (Henry Ford Health System)G3-CA4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin modulators
TargetsTubulin
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHenry Ford Health System
China Registration ClassN/A

Develop Information

Active CompaniesHenry Ford Health System
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A